AstraZeneca to buy Alexion for $39 billion to expand in immunology

The British company said the boards of both companies had approved the deal which, subject to regulatory and shareholder approval, is expected to close in the third quarter of 2021.

from The Hindu - Business https://ift.tt/2JOGOq8
via IFTTT